Extracorporeal shock wave lithotripsy monotherapy for staghorn stones with the second generation lithotriptors.
We reviewed 50 patients with staghorn stones to determine whether extracorporeal shock wave lithotripsy monotherapy is a successful alternative to the classical approaches (open operation versus percutaneous lithotripsy alone or with extracorporeal shock wave lithotripsy). Results free of stones at long-term followup (greater than 3 months) were obtained in 28 of 50 patients (56%) and when we included residual fragments with a diameter of less than 4 mm. (9 patients, or 18%) an over-all success rate of 74% (37 patients) was achieved. Of the patients 41 had a Double-J stent to improve fragment evacuation (5 experienced obstructive elimination), while uncomplicated evacuation was noted in the remaining 9 without a stent. No case of septicemia after extracorporeal shock wave lithotripsy was observed but all patients had received strict antimicrobial prophylaxis.
Vandeursen
H
H
Department of Urology, University Hospital St-Pieter, Katholieke Universiteit, Leuven, Belgium.
Baert
L
L
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007669:Kidney Calculi / Q000628:therapy*; D007682:Kidney Pelvis; D008096:Lithotripsy / Q000295:instrumentation*; D008297:Male; D008875:Middle Aged; D011292:Premedication; D018805:Sepsis / Q000517:prevention & control; D013997:Time Factors
D000900:Anti-Bacterial Agents